Labcorp (LH)
(Delayed Data from NYSE)
$207.67 USD
+1.52 (0.74%)
Updated May 10, 2024 04:00 PM ET
After-Market: $207.71 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
LH 207.67 +1.52(0.74%)
Will LH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for LH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LH
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
LH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
Integer Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up
Other News for LH
Fortrea Holdings: Still Many Question Marks On This CRO Play
Labcorp Announces Live Stream of Shareholders’ Meeting
Labcorp to Webcast Its Annual Meeting of Shareholders
Invitae Receives Court Approval for Sale to Labcorp
Invitae receives court approval for sale to Labcorp